JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

Search

Accuray Inc

Geschlossen

BrancheGesundheitswesen

1.59 0.63

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.58

Max

1.6400000000000001

Schlüsselkennzahlen

By Trading Economics

Einkommen

2.4M

1.1M

Verkäufe

14M

128M

Gewinnspanne

0.88

Angestellte

990

EBITDA

9.4M

10M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+272.67% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

50M

190M

Vorheriger Eröffnungskurs

0.96

Vorheriger Schlusskurs

1.59

Nachrichtenstimmung

By Acuity

51%

49%

304 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Accuray Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Okt. 2025, 20:49 UTC

Ergebnisse

Correction to Thermo Fisher Article on Oct. 22

23. Okt. 2025, 23:51 UTC

Market Talk

WiseTech Bull Cheered by DSV's Freight Volumes -- Market Talk

23. Okt. 2025, 23:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. Okt. 2025, 23:49 UTC

Market Talk

Nikkei May Rise on Hopes for Easing U.S.-China Tensions -- Market Talk

23. Okt. 2025, 23:37 UTC

Market Talk

Gold Falls on Likely Further Unwinding of Long Positions -- Market Talk

23. Okt. 2025, 22:58 UTC

Market Talk

Global Energy Roundup: Market Talk

23. Okt. 2025, 22:57 UTC

Market Talk

Woodside's Deal With Williams Eases Risks on Louisiana LNG Project -- Market Talk

23. Okt. 2025, 22:49 UTC

Akquisitionen, Fusionen, Übernahmen

How Trump Sparked a New Era of State Capitalism -2-

23. Okt. 2025, 22:49 UTC

Akquisitionen, Fusionen, Übernahmen

How Trump Sparked a New Era of State Capitalism -- Barrons.com

23. Okt. 2025, 22:17 UTC

Ergebnisse

Intel Shows Progress in First Earnings Report Since U.S. Investment -- 3rd Update

23. Okt. 2025, 21:41 UTC

Ergebnisse

Intel Shows Progress in First Earnings Report Since U.S. Investment -- 2nd Update

23. Okt. 2025, 21:05 UTC

Ergebnisse

Valero Earnings Show Why Refiners Are Energy's Big Winners This Year -- Barrons.com

23. Okt. 2025, 20:50 UTC

Market Talk
Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

23. Okt. 2025, 20:50 UTC

Market Talk
Ergebnisse

Auto & Transport Roundup: Market Talk

23. Okt. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23. Okt. 2025, 20:35 UTC

Ergebnisse

These Stocks Moved the Most Today: Tesla, IBM, D-Wave Quantum, Dow Inc., Molina Healthcare, Las Vegas Sands, Southwest, and More -- Barrons.com

23. Okt. 2025, 20:28 UTC

Ergebnisse

Intel Shows Progress in First Earnings Report Since U.S. Investment -- Update

23. Okt. 2025, 20:15 UTC

Market Talk
Ergebnisse

Global Commodities Roundup: Market Talk

23. Okt. 2025, 20:10 UTC

Ergebnisse

Newmont Mining 3Q Adj EPS $1.71

23. Okt. 2025, 20:10 UTC

Ergebnisse

Newmont Mining 3Q Sales $5.52B

23. Okt. 2025, 20:10 UTC

Ergebnisse

Newmont Mining 3Q EPS $1.67

23. Okt. 2025, 20:09 UTC

Ergebnisse

Intel Stock Rises After Strong Earnings. CFO Says Chip Demand Will Outpace Supply Into Next Year. -- Barrons.com

23. Okt. 2025, 20:07 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

23. Okt. 2025, 20:07 UTC

Market Talk
Ergebnisse

Ford Scrambles to Mitigate New Costs from Supplier Fire -- Market Talk

23. Okt. 2025, 20:07 UTC

Ergebnisse

Blackstone Looks to IPOs for Investment Exits -- Update

23. Okt. 2025, 20:05 UTC

Ergebnisse

Intel 3Q Gross Margin 38.2% >INTC

23. Okt. 2025, 20:04 UTC

Ergebnisse

Intel CFO: 'Current Demand Is Outpacing Supply, a Trend We Expect Will Persist Into 2026' >INTC

23. Okt. 2025, 20:04 UTC

Ergebnisse

Intel Shows Progress in First Earnings Report Since U.S. Investment -- WSJ

23. Okt. 2025, 20:04 UTC

Ergebnisse

Intel: 4Q Guidance Excludes Altera >INTC

23. Okt. 2025, 20:04 UTC

Ergebnisse

Intel Sees 4Q Adj EPS 8c >INTC

Peer-Vergleich

Kursveränderung

Accuray Inc Prognose

Kursziel

By TipRanks

272.67% Vorteil

12-Monats-Prognose

Durchschnitt 6 USD  272.67%

Hoch 7 USD

Tief 5 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Accuray Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

2

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

1.28 / 1.61Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

304 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
help-icon Live chat